Exploring the Role of Alcohol Metabolizing Genotypes in a 12-Week Clinical Trial of Naltrexone for Alcohol Use Disorder

<b>Background:</b> The efficacy of naltrexone in the treatment of alcohol use disorder (AUD) has been associated with a set of variables not directly related with the expression of opioid receptors. All the variables have been found to be highly associated with AUD itself or more severe clinical lev...

Descripció completa

Dades bibliogràfiques

Autors principals:	João M. Castaldelli-Maia, André Malbergier, Adriana B. P. de Oliveira, Ricardo A. Amaral, André B. Negrão, Priscila D. Gonçalves, Antonio Ventriglio, Domenico de Berardis, Juliana de Antonio, Isabela Firigato, Gilka J. F. Gattás, Fernanda de Toledo Gonçalves
Format:	Artigo
Idioma:	Inglês
Publicat:	MDPI AG 2021-10-01
Col·lecció:	Biomolecules
Matèries:	alcohol naltrexone genotyping <i>ADH1B</i> <i>ADH1C</i> <i>ALDH2</i>
Accés en línia:	https://www.mdpi.com/2218-273X/11/10/1495
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!